Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Santi Mandal and Trinath Chowdhury.
Santi Mandal
Connection Strength
2.505
Trinath Chowdhury
  1. In Silico Identification of a Potent Arsenic Based Approved Drug Darinaparsin against SARS-CoV-2: Inhibitor of RNA Dependent RNA polymerase (RdRp) and Essential Proteases. Infect Disord Drug Targets. 2021; 21(4):608-618.
    View in: PubMed
    Score: 0.922
  2. LPD-12: a promising lipopeptide to control COVID-19. Int J Antimicrob Agents. 2021 Jan; 57(1):106218.
    View in: PubMed
    Score: 0.912
  3. Probiotics-Derived Peptides and Their Immunomodulatory Molecules Can Play a Preventive Role Against Viral Diseases Including COVID-19. Probiotics Antimicrob Proteins. 2021 06; 13(3):611-623.
    View in: PubMed
    Score: 0.229
  4. Synergy of melanin and vitamin-D may play a fundamental role in preventing SARS-CoV-2 infections and halt COVID-19 by inactivating furin protease. Transl Med Commun. 2020; 5(1):21.
    View in: PubMed
    Score: 0.228
  5. Fusion Protein Targeted Antiviral Peptides: Fragment-Based Drug Design (FBDD) Guided Rational Design of Dipeptides Against SARS-CoV-2. Curr Protein Pept Sci. 2020; 21(10):938-947.
    View in: PubMed
    Score: 0.215
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.